What is the minimum age for receiving the shingles vaccine (Shingrix) in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Minimum Age for Shingles Vaccine (Shingrix)

You must be at least 50 years old to receive Shingrix, unless you are immunocompromised, in which case you can receive it starting at age 18. 1, 2

Standard Age Recommendation

  • The FDA approved Shingrix for adults aged 50 years and older as the standard indication for herpes zoster prevention 2
  • The Advisory Committee on Immunization Practices (ACIP) recommends vaccination starting at age 50 years with the two-dose Shingrix series, administered 2-6 months apart 1, 3
  • This represents a change from older guidelines that previously recommended starting vaccination at age 60 years with the now-inferior live-attenuated vaccine (Zostavax) 1

Why Age 50 Is the Threshold

  • Herpes zoster incidence increases substantially with age, making vaccination most beneficial starting at age 50 when risk begins to rise significantly 4
  • The pivotal clinical trials (ZOE-50 and ZOE-70) that established Shingrix's 97.2% efficacy specifically enrolled adults aged 50 years and older, not younger populations 1, 5
  • Multiple international guidelines from the United States, Canada, Taiwan, and the United Kingdom consistently recommend age 50 as the starting point for immunocompetent adults 4

Critical Exception: Immunocompromised Adults

If you are immunocompromised, you can receive Shingrix starting at age 18 years. 6, 2

This includes adults who:

  • Have HIV/AIDS or other immunodeficiency diseases 6
  • Are receiving immunosuppressive therapy (chemotherapy, high-dose steroids ≥20 mg/day prednisone equivalent, JAK inhibitors, biologics) 6
  • Have hematologic malignancies or solid organ cancers 6
  • Are solid organ or hematopoietic stem cell transplant recipients 6
  • Have autoimmune diseases requiring chronic immunosuppression 6

For immunocompromised patients under age 50, the vaccination schedule is shortened: first dose at Month 0, second dose at 1-2 months (rather than the standard 2-6 months) 6, 2

Important Caveats

  • Do not confuse shingles vaccine with chickenpox (varicella) vaccine - Shingrix is not indicated for prevention of primary varicella infection 6, 2
  • If someone has never had chickenpox and is not immune to varicella-zoster virus, they need varicella vaccine first, not Shingrix 6
  • Prior history of shingles does not change the age recommendation - you still need to wait until age 50 (or age 18 if immunocompromised) 1
  • The live-attenuated vaccine (Zostavax) remains contraindicated in immunocompromised patients of any age; only Shingrix is appropriate for this population 6

References

Guideline

Shingles Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

SHINGRIX Vaccination Schedule for Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Special Indications for Shingrix Under Age 50

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What type of varicella-zoster (VZV) vaccine is recommended for use in an adult?
At what age is the shingles vaccine (Recombinant Zoster Vaccine (RZV)) recommended for adults?
How long should an adult wait after having herpes zoster (shingles) before receiving the Shingrix (recombinant zoster vaccine) vaccine?
Should a 50-year-old patient with a history of Shingrix (Recombinant Zoster Vaccine) vaccination 2 years ago, who is experiencing a breakthrough case of shingles and is currently on Valacyclovir (Valacyclovir hydrochloride), receive a Shingrix booster shot?
What is the most appropriate additional vaccine to administer to a 50-year-old adult with a history of chickenpox and no history of shingles?
One week after pituitary surgery, an adult patient has mild hyponatremia with elevated urine osmolality; what is the next step in management?
What augmenting agents can be used to manage the side effects of lithium therapy?
What are the evidence‑based treatment strategies for trichotillomania?
What is the most likely diagnosis and urgent management for a patient with Hb 118 g/L, MCV 100 fL, platelets 110 ×10⁹/L, target cells, neutrophil vacuoles, INR 1.82, elevated bilirubin and alkaline phosphatase, and creatinine 115 µmol/L?
What potential post‑procedure issue should be warned to a patient after endoscopic variceal band ligation for bleeding esophageal varices?
What is a reasonable first‑line antibiotic regimen for an adult with community‑acquired pneumonia who has no known drug allergies or severe comorbidities?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.